Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 28;9(1):46.
doi: 10.3390/jof9010046.

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality

Affiliations

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality

Caleb P Skipper et al. J Fungi (Basel). .

Abstract

Cryptococcus is the leading cause of AIDS-related meningitis in sub-Saharan Africa. The clinical implications of a sterile cerebrospinal fluid (CSF) culture among individuals diagnosed with cryptococcal meningitis using CSF cryptococcal antigen (CrAg) are unclear. We prospectively enrolled 765 HIV-positive Ugandans with first-episode cryptococcal meningitis from November 2010 to May 2017. All persons were treated with amphotericin-based induction therapy. We grouped participants by tertile of baseline CSF quantitative Cryptococcus culture burden and compared clinical characteristics, CSF immune profiles, and 18-week mortality. We found 55 (7%) CSF CrAg-positive participants with sterile CSF cultures. Compared to the non-sterile groups, participants with sterile CSF cultures had higher CD4 counts, lower CSF opening pressures, and were more frequently receiving ART. By 18 weeks, 47% [26/55] died in the sterile culture group versus 35% [83/235] in the low culture tertile, 46% [107/234] in the middle tertile, and 56% [135/241] in the high tertile (p < 0.001). The sterile group had higher levels of CSF interferon-gamma (IFN-γ), IFN-α, interleukin (IL)-6, IL-17, G-CSF, GM-CSF, and chemokine CXCL2 compared with non-sterile groups. Despite persons with sterile CSF cultures having higher CD4 counts, lower CSF opening pressures, and CSF cytokine profiles associated with better Cryptococcus control (e.g., IFN-γ predominant), mortality was similar to those with higher fungal burdens. This unexpected finding challenges the traditional paradigm that increasing CSF fungal burdens are associated with increased mortality but is consistent with a damage-response framework model.

Keywords: AIDS; Cryptococcus; HIV; cryptococcal meningitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier Curve of 18-week Survival by CSF Fungal Burden Tertile in Cryptococcal Meningitis. Figure 1 demonstrates cumulative survival probability by Kaplan–Meier curve with Log Rank testing. At 18 weeks, the high tertile group has the poorest survival with 56% [135/241] dead, followed by the sterile culture group with 47% [26/55] dead, the middle tertile group with 46% [107/234] dead, and the low tertile group with 35% [83/235] dead. Log Rank p-value is calculated across all groups. CSF quantitative culture tertiles: Low Tertile = 1–14,700 CFU/mL; Middle Tertile = 14,701–206,000 CFU/mL; High Tertile > 206,000 CFU/mL.
Figure 2
Figure 2
Simplified Damage-Response Parabolic Framework Model of Cryptococcal Meningitis Disease. Figure 2 demonstrates a hypothesized damage-response model for HIV-associated cryptococcal disease. The model proposes that clinical disease can occur by either of two mechanisms: (1) Uncontrolled fungal dissemination characterized by suboptimal IFN-γ predominated Type 1 helper (Th1) response with increasing CSF quantitative culture burden, or (2) Excessive damaging host immune response characterized by exaggerated IFN-γ predominated Th1 host response with persons presenting with sterile CSF cultures. The host is most likely protected by a moderate, balanced immune response. (Figure is originally adapted from Pirofski and Casadevall concept, and further modified from our prior publication [29]).

References

    1. Durski K.N., Kuntz K.M., Yasukawa K., Virnig B.A., Meya D.B., Boulware D.R. Cost-effective diagnostic checklists for meningitis in resource-limited settings. J. Acquir. Immune Defic. Syndr. 2013;63:e101–e108. doi: 10.1097/QAI.0b013e31828e1e56. - DOI - PMC - PubMed
    1. Ellis J., Bangdiwala A.S., Cresswell F.V., Rhein J., Nuwagira E., Ssebambulidde K., Tugume L., Rajasingham R., Bridge S.C., Muzoora C., et al. The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017. Open Forum Infect. Dis. 2019;6:ofz419. doi: 10.1093/ofid/ofz419. - DOI - PMC - PubMed
    1. Rajasingham R., Govender N.P., Jordan A., Loyse A., Shroufi A., Denning D.W., Meya D.B., Chiller T.M., Boulware D.R. The global burden of HIV-associated cryptococcal infection in adults in 2020: A modelling analysis. Lancet Infect. Dis. 2022;22:1748–1755. doi: 10.1016/S1473-3099(22)00499-6. - DOI - PMC - PubMed
    1. Boulware D.R., Rolfes M.A., Rajasingham R., von Hohenberg M., Qin Z., Taseera K., Schutz C., Kwizera R., Butler E.K., Meintjes G., et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg. Infect. Dis. 2014;20:45–53. doi: 10.3201/eid2001.130906. - DOI - PMC - PubMed
    1. Jarvis J.N., Bicanic T., Loyse A., Namarika D., Jackson A., Nussbaum J.C., Longley N., Muzoora C., Phulusa J., Taseera K., et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: Implications for improving outcomes. Clin. Infect. Dis. 2014;58:736–745. doi: 10.1093/cid/cit794. - DOI - PMC - PubMed